updated 5/11/2011 9:17:18 AM ET 2011-05-11T13:17:18

BEIJING, May 11, 2011 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company"), a leading China-based biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hospital-based medical products, today announced that the Company plans to release first quarter 2011 financial results on Wednesday, May 25, 2011 after the market closes.

The Company will hold a conference call at 8:00 am ET on Thursday, May 26, 2011 to discuss first quarter 2011 results. Listeners may access the call by dialing:

United States toll free: 1-866-214-5335
China toll free:  400-6988181
Hong Kong toll free:  800-965084
United Kingdom toll free: 0800-0322281
International: 1-718-354-1231
Conference ID: 66845827

A telephone replay will be available beginning two hours after the conclusion of the call and will be available through June 8, 2011. Listeners may access the replay by dialing:

United States toll free:  1-866-214-5335
International:  1-718-354-1232
Conference ID: 66845827

A webcast will also be available through the Company's website www.nkbp.com .  

About China Nuokang Bio-Pharmaceutical Inc.

China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) is a leading biopharmaceutical company in China focused on the research, development, manufacture, marketing and sales of hospital-based medical products. The Company provides a diversified portfolio of products across more than 2,400 hospitals in China. Nuokang's principal products include Baquting®, China's leading hemocoagulase product by market share, and Kaitong® , a lipid emulsion alprostadil product for the treatment of peripheral vascular diseases, cardiocerebral microcirculation disorders and post-surgery thrombosis,. The Company's product pipeline includes product candidates under development in hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention. Please visit www.nkbp.com for more information. 

         In the U.S.: 
         Ashley M. Ammon: 

         In China: 
         Wen Lei Zheng: 

© Copyright 2012, GlobeNewswire, Inc. All Rights Reserved


Discussion comments


Most active discussions

  1. votes comments
  2. votes comments
  3. votes comments
  4. votes comments

Data: Latest rates in the US

Home equity rates View rates in your area
Home equity type Today +/- Chart
$30K HELOC FICO 3.79%
$30K home equity loan FICO 4.99%
$75K home equity loan FICO 4.69%
Credit card rates View more rates
Card type Today +/- Last Week
Low Interest Cards 13.83%
Cash Back Cards 17.80%
Rewards Cards 17.18%
Source: Bankrate.com